FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.377
EU - Europa 7.670
AS - Asia 5.759
SA - Sud America 884
Continente sconosciuto - Info sul continente non disponibili 299
AF - Africa 156
OC - Oceania 11
Totale 30.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.051
IT - Italia 2.151
GB - Regno Unito 2.045
SG - Singapore 1.735
CN - Cina 1.568
DE - Germania 892
VN - Vietnam 770
BR - Brasile 693
SE - Svezia 627
HK - Hong Kong 509
FR - Francia 439
RU - Federazione Russa 293
FI - Finlandia 263
UA - Ucraina 261
BD - Bangladesh 233
PL - Polonia 198
TR - Turchia 187
CA - Canada 174
KR - Corea 161
IN - India 160
BG - Bulgaria 93
NL - Olanda 81
JP - Giappone 69
MX - Messico 64
AR - Argentina 63
ID - Indonesia 62
IQ - Iraq 60
ZA - Sudafrica 52
BE - Belgio 45
ES - Italia 41
IE - Irlanda 41
AE - Emirati Arabi Uniti 35
CH - Svizzera 34
LT - Lituania 33
PK - Pakistan 32
AT - Austria 29
CL - Cile 24
EC - Ecuador 23
SA - Arabia Saudita 23
CO - Colombia 22
UZ - Uzbekistan 22
MA - Marocco 19
VE - Venezuela 19
JM - Giamaica 18
MY - Malesia 18
PH - Filippine 18
CR - Costa Rica 15
CZ - Repubblica Ceca 15
PT - Portogallo 15
PY - Paraguay 15
DZ - Algeria 14
EG - Egitto 14
AZ - Azerbaigian 13
JO - Giordania 12
DK - Danimarca 11
ET - Etiopia 11
IR - Iran 11
KE - Kenya 11
HU - Ungheria 10
PE - Perù 10
TN - Tunisia 10
HN - Honduras 9
BO - Bolivia 8
BY - Bielorussia 8
GT - Guatemala 8
AU - Australia 7
BH - Bahrain 7
EU - Europa 7
AL - Albania 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
RO - Romania 6
SN - Senegal 6
TW - Taiwan 6
UY - Uruguay 6
GR - Grecia 5
KZ - Kazakistan 5
MD - Moldavia 5
SV - El Salvador 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
IL - Israele 4
LV - Lettonia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
TZ - Tanzania 4
EE - Estonia 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NG - Nigeria 3
PR - Porto Rico 3
PS - Palestinian Territory 3
TH - Thailandia 3
Totale 29.828
Salva come PNG Salva come JPEG
Città #
Ashburn 1.806
Southend 1.466
Fairfield 1.295
Santa Clara 1.158
Singapore 1.058
Woodbridge 890
Chandler 753
San Jose 637
Houston 604
Seattle 532
Ann Arbor 512
Hong Kong 497
Cambridge 469
Jacksonville 468
Dearborn 458
Council Bluffs 446
Wilmington 445
Hefei 392
Frankfurt am Main 389
Nyköping 363
Beijing 291
Modena 277
London 242
Ho Chi Minh City 224
New York 211
Los Angeles 201
Hanoi 185
Helsinki 161
Chicago 155
Milan 147
Seoul 146
Kraków 145
The Dalles 123
Princeton 100
San Diego 92
Sofia 92
Izmir 91
Munich 89
Eugene 87
Shanghai 87
Moscow 85
Lauterbourg 82
Orem 77
Fremont 76
Buffalo 71
Redwood City 69
São Paulo 69
Rome 67
Boardman 60
Bologna 55
Porto Alegre 54
Dallas 53
Tokyo 52
Columbus 51
Bremen 46
Denver 45
Warsaw 43
Da Nang 42
Salt Lake City 41
Toronto 41
Atlanta 40
Brooklyn 40
Brussels 40
Dublin 40
Naples 39
Des Moines 35
Montreal 35
Phoenix 33
Guangzhou 32
Chennai 31
Jakarta 31
Verona 31
Grafing 30
Falls Church 28
Ottawa 27
Stockholm 27
Haiphong 26
Turku 26
Baghdad 25
San Francisco 25
Parma 24
Belo Horizonte 23
Cape Town 23
Amsterdam 22
Norwalk 22
Elk Grove Village 21
Marseille 19
Mumbai 19
Poplar 19
Tampa 19
Paris 18
Dhaka 17
Florence 17
Manchester 17
Mexico City 17
Miami 17
Milwaukee 17
Reggio Emilia 17
Austin 16
Biên Hòa 16
Totale 19.984
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 859
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 507
Metodo per la funzionalizzazione sito specifica di molecole proteiche 489
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 481
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 467
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 455
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 454
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 444
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 441
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 440
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 435
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 432
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 427
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 418
Antibacterial agent discovery using thymidylate synthase biolibrary screening 415
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 404
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 399
Allosteric Inhibition of human Thymidylate Synthase. 397
Biochemistry: Anchors away 396
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 394
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 392
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 388
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 385
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 383
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 378
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 375
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 370
Thymidylate synthase structure, function and implication in drug discovery 367
A proteomic approach to investigate the mechanism of action of anticancer peptides 367
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 364
Crystal Structure of histidine-tagged human thymidylate synthase 364
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 362
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 360
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 359
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 357
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 352
Current and Future Chemotherapy for Chagas Disease 352
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 348
ANTICANCER DRUGS 345
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 339
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 339
Biochemical effects of riluzole on Leishmania parasites 338
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 337
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 334
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 334
Homodimeric Enzymes as Drug Targets 330
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 326
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 326
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 325
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 324
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 324
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 323
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 319
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 313
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 310
Update on antifolate drugs targets 310
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 308
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 308
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 307
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 305
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 298
Target-based approaches for the discovery of new antimycobacterial drugs 288
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 282
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 282
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 273
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 272
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 269
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 267
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 261
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 260
Compounds having antiparasitic activity 260
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 258
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 252
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 248
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 246
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 240
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 235
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 230
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 226
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 218
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 218
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 217
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 214
Ovarian Cancer Drug Resistance 211
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 199
Medicinal chemistry in parasitology 198
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 190
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 188
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 166
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 147
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 142
Totale 30.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.621 0 0 0 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20267.959 456 309 563 906 1.222 557 1.036 388 834 794 455 439
2026/20271.953 208 551 615 579 0 0 0 0 0 0 0 0
Totale 30.156